 |
Abraaj exits Tunisia's Unimed via IPOThe Abraaj Group, a leading investor operating in global growth markets, has exited its investment in leading Tunisian pharmaceutical company Unité de fabrication de médicaments (Unimed) through an initial public offering (IPO) on More… |
|
Abraaj exits Tunisia's Unimed via IPOThe Abraaj Group, a leading investor operating in global growth markets, has exited its investment in leading Tunisian pharmaceutical company Unité de fabrication de médicaments (Unimed) through an initial public offering (IPO) on More… |
